8 Week Multi-site Study of MYDAYIS® for Bipolar Depression

Summary

This protocol is a Phase 2 multi-site study which aims to evaluate the safety and effectiveness of MYDAYIS\® as adjunctive therapy for adults with bipolar depression. Results from this study WILL NOT be used to contribute to an approval of MYDAYIS \® for this indication.

Timeline

Start

2020-07-17

Primary completion

2025-07-25

Completion

2025-07-25

Drugs

Indications